About
Science-Driven. Asia-Focused. Globally Connected.
ZM BioSci is an independent biomedical research foundation advancing disease screening programs across Asia, with a focus on metabolic, gastrointestinal, and neurodegenerative conditions.
Our Foundation
Established by Zhiming Intellectual Property Co. Ltd.
Founded in 2023, ZM BioSci is an independent biomedical research foundation funded by Zhiming Intellectual Property. Operating free from commercial pressure, we focus on long-term research and credible, peer-reviewed science
We actively engage with academic, and clinical partners on multi-center studies, while welcoming like-minded industry collaborators who share our vision for investment and development. As of 2023, we have supported 5 projects with over HKD 80 million in in-kind donations, including blood tests and equipment.
Our Mission
Built on Three Pillars
Rigorous Science
Every program is designed to meet the standards of international peer review, with reproducible methodology and transparent reporting.
International Collaboration
We actively seek multi-centre research partnerships with academic institutions, hospital networks, and clinical research organisations worldwide.
Population-Level Impact
Our research targets conditions with significant prevalence across Asian populations, where early screening can meaningfully change health outcomes.
Our Vision
A Healthier Asia Through Early Detection
Asia faces a growing burden of metabolic, gastrointestinal, and neurodegenerative disease. ZM BioSci exists to close the gap between population-level risk and clinical awareness — through rigorous community research, international collaboration, and a long-term commitment to the region's health.